{"name":"Immune Technologies & Medicine GmbH","slug":"immune-technologies-medicine-gmbh","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiZ0FVX3lxTE1IWGt0aHk5LV9Ra2l3Z2FqQXB5am1RODZZaVIydHJvM2ZMX2R6bFJ4R0VGWjAwU25CdkYzY1VocnAwcGpTcnJTNXhYVU9zanB6Sk5pbE9NVk1OMURLeHM3VEdkWGRlcnPSAWxBVV95cUxOV05WRWNUVmU1Zy1QRzNXQlBwQjlUb2xieU91ekx1SmNQcXEwQ2dxVkxtaThLd21uUzFiaE1pWEVZVVJ3dUQ1RjNTelpyb3hyLVlHa3ZyT3Y5c0ZTQUM2MFRaTFNEYkp2X2E0N3c?oc=5","date":"2026-03-05","type":"pipeline","source":"BioInformant","summary":"The Pipeline for iPSC-Derived Cell Therapeutics in 2026 - BioInformant","headline":"The Pipeline for iPSC-Derived Cell Therapeutics in 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwJBVV95cUxQY2ZIX2hfN21FTVFENzJxR29wMWR1dEp5NlBiVmJOSUtQaWttOVN3b3M4Q0w3UVJ4UklnUjJrTGxVcWN5OWswLTJycWlXZmpvWmRja1Y5MmRyMkRwSEtQQVNMamFzU0hnOEcyNFozX1hkT2JyRU1QbzdOOEllczR0SUpxSkwxLVRCN1M3a2lkazBwZ1ZRMGotU3ozeDM5VHpSd0QyanMydHFGcS1GTVBsWExqVXNnVk51WFRBMFZJa0VqemN4UVRhSHJzNTludjhhM3pwQzI5ei1ad0tXQ0FDVWpDcjJQeTNXNXpkRFFCUjhGWmxYM04xcFI5RHRJZjJPbEJMczhpaWhoZXotSmFuTUVELWNRaTlFRnktei1PWXZZWG9ZOTJvTlZsNTNjeWs?oc=5","date":"2026-02-11","type":"deal","source":"PR Newswire","summary":"Evogene, Systasy and LMU University Hospital Munich Announce a Collaboration to Develop Novel Therapies for Neutrophil-Derived Inflammatory Diseases - PR Newswire","headline":"Evogene, Systasy and LMU University Hospital Munich Announce a Collaboration to Develop Novel Therapies for Neutrophil-D","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxNR2VzcVJEN1NiSXh3WHR2Zi1GeHVOa252YnJqcWVjTEkyUWJiSWdHR1N2UlhTX3ZDZGRjRktMYkJqT3pUU3dVMzIydGhUOURkb0xYMGlEcGtobk1MLWtKSFlub043RXJuWmZRakVnRmhXMVM1TjBVRVRnYVBqNFdWaTJrNVZtUTBBSVhGcm5MUG0?oc=5","date":"2026-01-20","type":"pipeline","source":"PharmTech.com","summary":"Proteasomes: A Novel Approach to Target the Immune System - PharmTech.com","headline":"Proteasomes: A Novel Approach to Target the Immune System","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxQSDBXZ243SnRELU9tTG5VZTBBaUFIQkVwVmJEYW42OGc5emVxOWVhSGlZcng5U1RDZE5IWUM5YUdYRE1VSDBpVFZxTW5iNUF0X29DSUlDa3RBaHpKRmhwODNuU1hlRmEyQzNDLU9VUlVYN29vb3dTZFl1T21FU2FWNXpGZklzS2hZQXNoV21KczXSAZYBQVVfeXFMTmdVSG5xdU5Qa2JKdFpoQWYyaHhkUkxfM1FUdmljWjc5Z2VZYkxxRzhsa0VmZWZXc2h1UWY4MFFibXlwbXplT0VBS2dITk5ya1oxVlRwN3JJUF9fOFkwQlZ5eHB1NmNwRWZQV0NvMVlmSDZka3laZlZTMjNaN1FXdWxiU0hUSC1XckpWb09qRGNVSDI3UXdR?oc=5","date":"2026-01-17","type":"pipeline","source":"BioInformant","summary":"CAR-T Cell Companies Proliferate: List of CAR-T Companies Worldwide - BioInformant","headline":"CAR-T Cell Companies Proliferate: List of CAR-T Companies Worldwide","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE1fd2x3N1FSaTc5eERuWXhJTDlZLTIzWHdfVmdqUi1ONmxuekg2a2hBVTVPU2tJMTZCLWpkZGNyR3ZmQVVSRGVaeks4cUpRNDFsQUJjUDJtMVNYNnVKMk5N?oc=5","date":"2025-08-01","type":"pipeline","source":"nature.com","summary":"Design specifications for biomedical virtual twins in engineered adoptive cellular immunotherapies - nature.com","headline":"Design specifications for biomedical virtual twins in engineered adoptive cellular immunotherapies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidkFVX3lxTFBLSFJMRjJFOC1KZUdCRHpTemZHaVFtMWZMWjFtVDRqWXA3Y05YQzQyZmoyWTdsX2hyUXM5M2ZiMHJ5NnBXbWF6VDRkRURORlZwY0lWbExna1dEMlFDZHc5aFNwM3MxYUZjMG9QMDhkb21Lbkd1VGc?oc=5","date":"2025-07-06","type":"pipeline","source":"ScienceDirect.com","summary":"Nemolizumab (Nemluvio®) for prurigo nodularis - ScienceDirect.com","headline":"Nemolizumab (Nemluvio®) for prurigo nodularis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFBYNlpORUtLeE9NOGlBX1FKZXI4S21IZGRicGxoRjcteTlmbl9xajEtaDdyV3BsSHZqWk5YRUlWd0ZYZVdlb2RWNUNxM3ppNUNzQWM0UWdCTldPekFSTVhR?oc=5","date":"2025-05-15","type":"pipeline","source":"nature.com","summary":"How organoids could shape biomedical research - nature.com","headline":"How organoids could shape biomedical research","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5wFBVV95cUxPanhOcXd1NU5pNHlCY045NWR6LVdnU0NCYm0wSnpOeUR1dUExVzcwU3lfSVFINkJlMF9iLTdnWWlwa3dNME9OVndRY2pQT1FsRmE1VC1PZHl3N2w2a09ZRE83NEpFOHdnb0JaWHlqV1EtdjhYdnFweEhXNG9vUjF2YzRfaXczRlYzQ3FtQlpfeTlwSDVJT3FDdHdBbzU2SFRQRThvS2NGc0trX2VWZW9Kb0tnVzE2bXhSUVAzUHRRV2xnTlRkMGpxc0xBTlN0WmhTeUR6MzZSMWdZQlJUby1nR0pVdFI5MkU?oc=5","date":"2025-02-21","type":"pipeline","source":"Citeline News & Insights","summary":"Scrip Asks... What Does 2025 Hold For Biopharma? Part 6: Therapeutic Area Advances - Citeline News & Insights","headline":"Scrip Asks... What Does 2025 Hold For Biopharma? Part 6: Therapeutic Area Advances - Citeline News & Insights","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxOVmZiVDZ1Ty1TVERsSFlIU21ZRVlOQ0x5MGxmTHBZYXdZWlR5LTVPcW4zSkN1c1p4ZGd6cldpMlUwOHJhdkRLUFhTVmkyVlhzWE9JRy1MdnFhSTAzTDczRnMyNTUyNE5oVzRLUzk0WVNSaWZDeHktOEg5azJGQ0Y1TllBOFBjUjFUbVhkZnVvMEg3VWdHazVqcDFFeG1lS09lbjZGOTdSN0txS3J4a3RJcmZjZWtoRGxHOUNqbg?oc=5","date":"2024-07-29","type":"deal","source":"Boehringer Ingelheim","summary":"Boehringer Ingelheim acquires Nerio Therapeutics - Boehringer Ingelheim","headline":"Boehringer Ingelheim acquires Nerio Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxNaGFRMHFFVlBvMWJDa2x0b1Fzb0FiVTBMVDFWem52YWRIS3V1a0RnUnQ4V0hpU2QtMTdMLTAyOC02LWV5dWd2NzZzNDlMTkhXRmxvazhVMUY4SERoV2E0YmxmNFBhR1J1N3BxNDN2anpSYXVfZlZXQXZYcW9OY2loMTVITDlZeW1GMEpibTg2TmNDaGVYX2ZLNjlqZk1leWR1ekE?oc=5","date":"2024-01-31","type":"deal","source":"Contract Pharma","summary":"Pharmaceutical Industry Mergers & Acquisitions Roundup - Contract Pharma","headline":"Pharmaceutical Industry Mergers & Acquisitions Roundup","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxPQnJzck5HQnI4SWhDeUxsYkhSdkFSWG9oN3M2YVdvM0tMRlVRbnVNR0I3X1JJY1YxSDNkeXdSVTdITU85aVlHRVMtVDdvOXZtcHM5VzNIMGZuT3ZrRXlXMUhzdUF0Y2V0S3pCSGIxWV81UDhXMHlkQ3E0ZDlPUVBTRnlibVBBZTFuSGpV?oc=5","date":"2023-03-10","type":"pipeline","source":"drugdiscoverytrends.com","summary":"The top 100 cell and gene therapy companies to watch in 2023 - drugdiscoverytrends.com","headline":"The top 100 cell and gene therapy companies to watch in 2023","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxNMXlWSjhyYTdGUDlfbEhpRmp0eDJUcHNnVlhoUm9Rc2JZWGtSRDlMRTdVaDhsSFdXZ21KMVVydzk2MGRDZzBqMklFdnBRdVpKMDlyb21LUVNKbG5kbUVJVWtMeHp2NllDQ3UyNklDaWp6TEtmTlQ5RXU1V09pbDY4R1hOODhSSTFfaUVBeG9jWnFla2lUOEZMZDJYMDVwc1NYYm1VTzljYWxLTmFnVGVJOVVabDY5UEhhMHhoS291eDJJZlE?oc=5","date":"2021-09-09","type":"pipeline","source":"Johns Hopkins Medicine","summary":"Right Program Could Turn Immune Cells into Cancer Killers - Johns Hopkins Medicine","headline":"Right Program Could Turn Immune Cells into Cancer Killers","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}